Pharmaceutical Research

Pharmaceutical Research

药物研究

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Pharmaceutical Research》是由Springer US出版社于1984年创办的英文国际期刊(ISSN: 0724-8741,E-ISSN: 1573-904X),该期刊长期致力于化学:综合领域的创新研究,主要研究方向为医学-化学综合。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.2388...%),以发表化学:综合领域等方向的原创性研究为核心(研究类文章占比90.11%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在182篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Pharmaceutical Research审稿周期约为 约3.0个月 。该刊近年未被列入国际预警名单,年发文量约182篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 182 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MULTIDISCIPLINARY 化学:综合 PHARMACOLOGY & PHARMACY 药学
3区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MULTIDISCIPLINARY 化学:综合 PHARMACOLOGY & PHARMACY 药学
3区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q2 88 / 230

62%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 100 / 354

71.9%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q2 72 / 231

69.05%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 123 / 354

65.4%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.6 SJR:0.707 SNIP:0.897
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q1 65 / 272

76%

大类:Medicine 小类:Organic Chemistry Q2 58 / 211

72%

大类:Medicine 小类:Pharmaceutical Science Q2 51 / 183

72%

大类:Medicine 小类:Pharmacology Q2 103 / 313

67%

大类:Medicine 小类:Biotechnology Q2 107 / 311

65%

大类:Medicine 小类:Molecular Medicine Q2 76 / 178

57%

期刊发文

  • Exosomes as Carriers for Drug Delivery in Cancer Therapy

    Author: Zeng, Weiping; Wen, Zhengbo; Chen, Honglin; Duan, Yuyou

    Journal: PHARMACEUTICAL RESEARCH. 2023; Vol. 40, Issue 4, pp. 873-887. DOI: 10.1007/s11095-022-03224-y

  • Optimized Cationic Lipid-assisted Nanoparticle for Delivering CpG Oligodeoxynucleotides to Treat Hepatitis B Virus Infection

    Author: Chen, Yi-Fang; Wang, Yan; Wang, Yue; Luo, Ying-Li; Lu, Zi-Dong; Du, Xiao-Jiao; Xu, Cong-Fei; Wang, Jun

    Journal: PHARMACEUTICAL RESEARCH. 2023; Vol. 40, Issue 1, pp. 145-156. DOI: 10.1007/s11095-022-03307-w

  • Melt Crystallization of Celecoxib-Carbamazepine Cocrystals with the Synchronized Release of Drugs

    Author: Chen, An; Cai, Peishan; Luo, Minqian; Guo, Minshan; Cai, Ting

    Journal: PHARMACEUTICAL RESEARCH. 2023; Vol. 40, Issue 2, pp. 567-577. DOI: 10.1007/s11095-022-03427-3

  • Bone-Targeted Dual Functional Lipid-coated Drug Delivery System for Osteosarcoma Therapy

    Author: Zhong, Jie; Wen, Weiye; Wang, Jinjin; Zhang, Mengyu; Jia, Yijiang; Ma, Xiaowei; Su, Yu-Xiong; Wang, Yuji; Lan, Xinmiao

    Journal: PHARMACEUTICAL RESEARCH. 2023; Vol. 40, Issue 1, pp. 231-243. DOI: 10.1007/s11095-022-03430-8

  • Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing Cancer

    Author: Ji, Afang; Xu, Minghao; Pan, Yunzhi; Diao, Lu; Ma, Lin; Qian, Li; Cheng, Junping; Liu, Mi

    Journal: PHARMACEUTICAL RESEARCH. 2023; Vol. 40, Issue 1, pp. 265-279. DOI: 10.1007/s11095-022-03445-1

  • A Spike-Control Approach that Evaluates High Resolution Mass Spectrometry-Based Sequence Variant Analytical Method Performance for Therapeutic Proteins

    Author: Zhang, Jinhui; Shih, Mack; Yan, Haoheng; O'Connor, Thomas; Ji, Chengjie; Faustino, Patrick J.

    Journal: PHARMACEUTICAL RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11095-023-03527-8

  • Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis

    Author: Shao, Zitong; Chow, Michael Y. T.; Chow, Shing Fung; Lam, Jenny K. W.

    Journal: PHARMACEUTICAL RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11095-023-03488-y

  • Physiologically Based Pharmacokinetic Modeling for Multiple Oral Administration Labetalol in Pregnant Women

    Author: Song, Yudi; Wang, Wei; Liu, Xinyang; Chen, Jingsi; Chen, Dunjin; Wang, Xiaoyi; Li, Wei; Ouyang, Defang

    Journal: PHARMACEUTICAL RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11095-023-03523-y